Doximity, Inc. (NASDAQ:DOCS) Position Raised by Covestor Ltd

Covestor Ltd lifted its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 441.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,680 shares of the company’s stock after buying an additional 1,370 shares during the period. Covestor Ltd’s holdings in Doximity were worth $73,000 at the end of the most recent reporting period.

Other institutional investors also recently added to or reduced their stakes in the company. LRI Investments LLC bought a new position in Doximity during the first quarter valued at about $27,000. Farther Finance Advisors LLC raised its position in Doximity by 324.2% during the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock valued at $34,000 after buying an additional 603 shares during the period. Blue Trust Inc. lifted its position in shares of Doximity by 621.4% in the second quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock worth $37,000 after purchasing an additional 1,193 shares in the last quarter. Quarry LP lifted its position in Doximity by 101.2% in the 2nd quarter. Quarry LP now owns 1,616 shares of the company’s stock worth $45,000 after buying an additional 131,253 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale purchased a new stake in shares of Doximity during the first quarter worth $46,000. Institutional investors and hedge funds own 87.19% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on DOCS shares. Canaccord Genuity Group reiterated a “hold” rating and issued a $60.00 target price (up from $40.00) on shares of Doximity in a research note on Wednesday. Robert W. Baird increased their target price on Doximity from $41.00 to $45.00 and gave the company an “outperform” rating in a research note on Tuesday, September 17th. Baird R W raised shares of Doximity to a “strong-buy” rating in a report on Tuesday, September 17th. Barclays lifted their price objective on Doximity from $52.00 to $75.00 and gave the stock an “overweight” rating in a report on Monday. Finally, Wells Fargo & Company raised shares of Doximity from an “underweight” rating to an “equal weight” rating and upped their target price for the company from $19.00 to $41.00 in a research note on Friday, November 8th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Doximity currently has a consensus rating of “Hold” and a consensus target price of $48.14.

Doximity Price Performance

Shares of Doximity stock opened at $52.88 on Thursday. The firm has a 50 day simple moving average of $42.48 and a 200 day simple moving average of $33.68. The firm has a market cap of $9.82 billion, a P/E ratio of 60.78, a P/E/G ratio of 5.08 and a beta of 1.30. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $61.75.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.